Orient EuroPharma Statistics

Total Valuation

TPEX:4120 has a market cap or net worth of TWD 4.75 billion. The enterprise value is 8.84 billion.

Market Cap	4.75B
Enterprise Value	8.84B

Important Dates

The next estimated earnings date is Thursday, February 27, 2025.

Earnings Date	Feb 27, 2025
Ex-Dividend Date	n/a

Share Statistics

TPEX:4120 has 86.75 million shares outstanding. The number of shares has increased by 0.23% in one year.

Current Share Class	n/a
Shares Outstanding	86.75M
Shares Change (YoY)	+0.23%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	13.80%
Owned by Institutions (%)	1.39%
Float	32.36M

Valuation Ratios

The trailing PE ratio is 24.92.

PE Ratio	24.92
Forward PE	n/a
PS Ratio	1.06
PB Ratio	0.91
P/TBV Ratio	0.92
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 30.29, with an EV/FCF ratio of -174.36.

EV / Earnings	46.30
EV / Sales	1.98
EV / EBITDA	30.29
EV / EBIT	109.43
EV / FCF	-174.36

Financial Position

The company has a current ratio of 0.98, with a Debt / Equity ratio of 0.85.

Current Ratio	0.98
Quick Ratio	0.60
Debt / Equity	0.85
Debt / EBITDA	15.68
Debt / FCF	-98.14
Interest Coverage	0.98

Financial Efficiency

Return on equity (ROE) is 5.07% and return on invested capital (ROIC) is 0.65%.

Return on Equity (ROE)	5.07%
Return on Assets (ROA)	0.56%
Return on Invested Capital (ROIC)	0.65%
Return on Capital Employed (ROCE)	1.27%
Revenue Per Employee	13.19M
Profits Per Employee	563,145
Employee Count	339
Asset Turnover	0.38
Inventory Turnover	1.97

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +36.25% in the last 52 weeks. The beta is 0.43, so TPEX:4120's price volatility has been lower than the market average.

Beta (5Y)	0.43
52-Week Price Change	+36.25%
50-Day Moving Average	49.16
200-Day Moving Average	47.53
Relative Strength Index (RSI)	74.00
Average Volume (20 Days)	227,401

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:4120 had revenue of TWD 4.47 billion and earned 190.91 million in profits. Earnings per share was 2.20.

Revenue	4.47B
Gross Profit	2.17B
Operating Income	106.18M
Pretax Income	415.69M
Net Income	190.91M
EBITDA	269.32M
EBIT	106.18M
Earnings Per Share (EPS)	2.20

Full Income Statement

Balance Sheet

The company has 1.55 billion in cash and 4.98 billion in debt, giving a net cash position of -3.43 billion or -39.53 per share.

Cash & Cash Equivalents	1.55B
Total Debt	4.98B
Net Cash	-3.43B
Net Cash Per Share	-39.53
Equity (Book Value)	5.88B
Book Value Per Share	60.19
Working Capital	-61.59M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 17.25 million and capital expenditures -67.94 million, giving a free cash flow of -50.69 million.

Operating Cash Flow	17.25M
Capital Expenditures	-67.94M
Free Cash Flow	-50.69M
FCF Per Share	-0.58

Full Cash Flow Statement

Margins

Gross margin is 48.44%, with operating and profit margins of 2.37% and 4.27%.

Gross Margin	48.44%
Operating Margin	2.37%
Pretax Margin	9.30%
Profit Margin	4.27%
EBITDA Margin	6.02%
EBIT Margin	2.37%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 1.82%.

Dividend Per Share	1.00
Dividend Yield	1.82%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	45.44%
Buyback Yield	-0.23%
Shareholder Yield	1.60%
Earnings Yield	4.02%
FCF Yield	-1.07%

Dividend Details

Stock Splits

The last stock split was on July 28, 2010. It was a forward split with a ratio of 1.16.

Last Split Date	Jul 28, 2010
Split Type	Forward
Split Ratio	1.16

Scores

TPEX:4120 has an Altman Z-Score of 0.89. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.89
Piotroski F-Score	n/a